1. |
Cancer, 1999; 86(9)∶ 1657.
|
2. |
Surgery, 2004; 135(3)∶ 266.
|
3. |
Blood, 1997; 89(6)∶ 1845.
|
4. |
J Natl Cancer Inst, 1997; 89(11)∶ 783.
|
5. |
Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials [J].
|
6. |
Koike H, Ichikawa D, Kitamura K, et al. Perinodal involvement of cancer cells in gastric cancer patients [J].
|
7. |
Hannun YA. Apoptosis and the dilemma of cancer chemotherapy [J].
|
8. |
Micheau O, Solary E, Hammann A, et al. Sensitization of cancer cells treated with cytotoxic drugs to fasmediated cytotoxicity [J].
|
9. |
Muller BM, Wilder S, Bannasch D, et al. p53 activates the CD95(APO1/Fas) gene in response to DNA damage by anticancer drugs [J]. J Exp Med, 1998; 188(11)∶2033.
|
10. |
孫碎康, 蒲青凡, 嚴律南, 等. 胃癌病人術前選擇性動脈栓塞化療對腫瘤血管的影響 [J]. 中國普通外科雜志, 2002; 11(4)∶202.
|
11. |
楊秀超, 崔振玉, 李正華. 經動脈插管灌注抗癌藥提高胃癌手術療效 [J]. 中華外科雜志, 1994; 32(7)∶ 403.
|
12. |
徐工學, 李志霞, 陳佛來, 等. 術前區域性動脈灌注化療對大腸癌細胞凋亡相關基因的影響 [J]. 中華外科雜志, 2001; 39(6)∶436.
|